RENGA, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 2.331
EU - Europa 1.853
AS - Asia 487
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.676
Nazione #
US - Stati Uniti d'America 2.312
IE - Irlanda 485
UA - Ucraina 368
SE - Svezia 254
IT - Italia 241
VN - Vietnam 156
HK - Hong Kong 154
FI - Finlandia 134
DE - Germania 102
RU - Federazione Russa 98
CN - Cina 91
FR - Francia 61
TR - Turchia 43
GB - Regno Unito 37
CH - Svizzera 21
SG - Singapore 19
CA - Canada 16
RO - Romania 13
KR - Corea 12
BE - Belgio 9
PL - Polonia 8
GR - Grecia 7
LB - Libano 5
NL - Olanda 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CZ - Repubblica Ceca 4
MX - Messico 3
UZ - Uzbekistan 3
BR - Brasile 2
EU - Europa 2
CL - Cile 1
ES - Italia 1
HU - Ungheria 1
Totale 4.676
Città #
Chandler 552
Dublin 484
San Mateo 254
Jacksonville 167
Dong Ket 156
Hong Kong 154
Altamura 140
Medford 119
Princeton 119
Lawrence 101
Andover 98
Wilmington 96
Ann Arbor 86
Perugia 57
Beijing 49
Des Moines 42
Izmir 42
Saint Petersburg 37
Ashburn 33
Boardman 30
Helsinki 20
Falls Church 16
Norwalk 16
San Paolo di Civitate 13
Timisoara 13
Woodbridge 13
Dearborn 12
New York 12
Ottawa 12
Los Angeles 11
Singapore 10
Brussels 9
Auburn Hills 6
Den Haag 5
Lausanne 5
Shanghai 5
Al Ain City 4
Houston 4
Moscow 4
Redwood City 4
Frankfurt Am Main 3
London 3
San Diego 3
Simi Valley 3
Toronto 3
Lappeenranta 2
Nanjing 2
Phoenix 2
Rovato 2
Stenico 2
São Paulo 2
Tappahannock 2
Alameda 1
Alba 1
Atatürk 1
Atlanta 1
Bisaccia 1
Bologna 1
Budapest 1
Cork 1
Deruta 1
Edinburgh 1
Foggia 1
Foligno 1
Fremont 1
Hanover 1
Hefei 1
Kiev 1
Kunming 1
Ludwigshafen 1
Miami 1
Moline 1
Montreal 1
Napoli 1
Pasadena 1
Philadelphia 1
Piacenza 1
Prague 1
Redmond 1
Rome 1
Salerno 1
San Jose 1
Seattle 1
Seoul 1
Shenyang 1
Tolentino 1
Turin 1
Vico Equense 1
Totale 3.075
Nome #
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 85
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 81
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 81
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 81
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 67
A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats. 66
Antiatherosclerotic effect of farnesoid X receptor. 66
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. 65
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 65
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. 62
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 61
Preliminary structure-activity relationship on theonellasterol, a new chemotype of FXR antagonist, from the marine sponge Theonella swinhoei. 61
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. 60
An essential role of Farnesoid X-Receptor in regulating intestinal fibrosis in murine model of chronic colitis 60
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 59
Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice 59
Administration of 3 alpha-6 alpha-dihydroxy-7a alpha-fluoro-5 beta-cholanoate (UPF-680) in chronic cholestasis induced by 17 alpha-ethynyl-estradiol (17 alpha EE) in rats. 58
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors. 58
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 57
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 57
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 56
Discovery of sulfated sterols from marine invertebrates as a new class of marine naturalantagonists of farnesoid-X-receptor. 53
Epigenetic Modulation of Adhesion and Proliferation Pathways by Methionine Deficiency Attenuates Potential for Dissemination of Gastric Cancer Cells 53
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 52
Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice. 51
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents. 51
The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice. 50
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 50
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 50
The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes 49
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa 49
The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease. 48
Farnesoid X receptor suppresses constitutive androstane receptoractivity at the multidrug resistance protein-4 promoter. 48
Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. 48
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 48
Counter-regulatory role of bile acid activated receptors in immunity andinflammation. 48
Role of the FXR in Regulating Bile Acid Homeostasis and Relevance for Human Diseases 47
The third gas: H2S regulates perfusion pressure in both theisolated and perfused normal rat liver and in cirrhosis. 47
4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. 47
Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. 47
Conicasterol E, a Small Heterodimer PartnerSparing Farnesoid X Receptor Modulator Endowed with a Pregnane X ReceptorAgonistic Activity, from the Marine Sponge Theonella swinhoei 46
Structural insights into Estrogen Related Receptor-β modulation: 4-methylenesterols from Theonella swinhoei sponge as the first example of marine natural antagonists. 46
Genetic Ablation and Pharmacological Blockade of CCR5 by the anti-HIV Small Molecule Inhibitor Maraviroc Inhibits Leukocyte Trafficking and Protects Against Mucosal Inflammation in Murine Models Colitis 46
Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. 45
Critical role of toll-like receptors in modulating GM-CSF activity in rodent models of colitis 45
FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity. 45
Nitric oxide (NO)-releasing naproxen (HCT-3012) interactions with aspirin in gastric mucosa of arthritic rats reveals a role for aspirin-triggered lipoxin, prostaglandins and NO in gastric protection. 43
Nitric oxide modulates proapoptotic and antiapoptotic properties of chemotherapy agents: the case of NO-pegylated epirubicin. 43
Inhibition of NF-κB by a PXR-dependent pathwaymediates counter-regulatory activities of rifaximin on innate immunity inintestinal epithelial cells. 43
The HIV Matrix Protein p17 promotes the Activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2 43
The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor (FXR)/9-cis retinoid X receptor and regulates transcription of FXR responsive genes. 42
The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate 42
Modification in the side chain of solomonsterol A: discovery of cholestan disulfate as a potent pregnane-X-receptor agonist 42
The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis. 41
Il valore predittivo del polimorfismo C-1237T del toll-like receptor 9 nell’eruzione eritemato-papulo-pustolosa da inibitori del fattore di crescita epidermico 41
Binding mechanism of the farnesoid X receptor marine antagonist suvanine reveals a strategy to forestall drug modulation on nuclear receptors. Design, synthesis, and biological evaluation of novel ligands. 41
The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. 41
SHP-dependent and -independent induction of peroxisomeproliferator-activated receptor-γ by the bile acid sensor farnesoid X receptorcounter-regulates the pro-inflammatory phenotype of liver myofibroblasts. 39
Polyhydroxylated sterols from the Indonesian softcoral Sinularia sp. and their effect on farnesoid X-activated receptor. 39
The methyl trasnferase PRMT1 functions as coactivator of FXR/RXR and regulates transcription of FXR responsive genein hepatocytes 39
Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands 39
The bile acid receptor FXR is a modulator of intestinal innate immunity. 39
Gene Expression Changes Induced by HIPEC in a Murine Model of Gastric Cancer 39
Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. 38
The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. 38
Farnesoid-X-receptor (FXR) ligands induce a small heterodimer partner (SHP)-dependent upregulation of PPAR-gamma in hepatic stellate cells and in rat model of liver fibrosis. 38
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination. 38
Cystathionine gamma-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids 38
Pregnane-X-receptor mediates the anti-inflammatoryactivities of rifaximin on detoxification pathways in intestinal epithelialcells. 37
Epigenetic modulation by methionine deficiency attenuates the potential for gastric cancer cell dissemination. 37
Inhibition of hydrogen sulfide generation contributes to gastric injury caused byanti-inflammatory nonsteroidal drugs. 36
Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling 36
Instruction of Intestinal Microbiota by VSL#3 Reverses NASH and Accelerated Atherosclerosis Caused by Intestinal Inflammation in ApoE(-/-) Mice 35
In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors. 35
Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain. 34
Il valore predittivo del polimorfismo C1237-T di TLR9 mutato nell’eruzione eritemato-papulo-pustolosa da inibitori dei recettori del fattore di crescita epidermico 32
Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity. 31
Solomonsterols A and B from Theonella swinhoei. The First Example of C-24 and C-23 Sulfated Sterols from a Marine Source Endowed with a PXR Agonistic Activity. 31
Co-administration of nitric oxide-aspirin (NCX-4016) andaspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans. 31
Protective effects of granulocyte macrophage colony stimulating factor (gm-Csf) in Hapten-induced colitis 31
Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1 31
Theonellasterols and conicasterols fromTheonella swinhoei. Novel marine natural ligands for human nuclear receptors. 30
Essential Role of DNAX Adaptor Protein 12 (DAP12) and Spleen Tyrosine Kinase (Syk) in Inflammation-Driven Immune Dysfunction in Rodent Model of Colitis 30
Insights on pregnane-X-receptor modulation. Natural and semisynthetic steroids from Theonella marine sponges. 30
‘The Farnesoid X Receptor Promotes Adipocyte Differentiationd regulates adipose cell function in vivo’ 29
Molecular Determinants of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Model of Peritoneal Gastric Cancer Carcinogenesis 29
H2S Induces Analgesia Is Mediated In Vivo Activation of mu Opioid Receptor and PI3K/AKT Pathway Activation 28
The bile acid sensor FXR regulates insulin transcription and secretion. 28
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma 28
A Novel Source of Intestinal Damage: The HIV Protease Inhibitor Ritonavir Worsens Damage Caused by COX Inhibitors 28
The CCR5 Antagonist Maraviroc Reduces the Potential for Gastric Cancer Dissemination in Rodent Models of Peritoneal Metastasis 28
Role of Nuclear Receptors in Lipid Dysfunction and Obesity-related Diseases. 28
Quantitative NMR-Derived Interproton Distances Combined with QuantumMechanical Calculations of (13)C Chemical Shifts in the StereochemicalDetermination of Conicasterol F, a Nuclear Receptor Ligand from Theonellaswinhoei. 28
HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes 27
The Bile Acid Receptor TGR5 Maintains Gastrointestinal Homeostasis and Its Activation Rescues From Gastrointestinal Injury Caused by ASA and NSAIDs 27
Enhanced anti-inflammatory activity of hydrogen sulfide releasing derivative of mesalamine in rodent models of colitis, involves direct inhibition of Nf-kappa B 27
Role of Maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced 27
Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. 27
The Bile Acid Sensor FXR Induces the Glucocorticoid Receptor in the Liver in a Promoter-Dependent Manner 25
Reciprocal Regulation of TLRS and Nuclear Receptors: IRF-7 Dependent Regulation of FXR Mediates Counter-Regulatory Effects of TLR-9 in Colitis 25
Totale 4.426
Categoria #
all - tutte 19.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.594

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201946 0 0 0 0 0 0 0 0 0 0 46 0
2019/2020387 23 16 44 2 53 28 72 16 79 36 4 14
2020/2021917 4 69 43 83 281 47 51 3 72 27 62 175
2021/2022898 14 167 9 48 31 10 10 342 6 13 92 156
2022/20231.798 129 344 11 175 135 188 0 89 662 2 47 16
2023/2024449 42 78 46 6 4 4 140 26 36 20 47 0
Totale 4.851